NFKB1 and Alzheimer disease: Wang et al. reported that gastrodin inhibits both the TLR4/TRAF6/NF-κB pathway and Stat3 signaling, reducing microglial activation, pro-inflammatory responses, and neuronal damage in neurodegenerative diseases such as AD (Wang et al., 2024a).